The Congressional Record is a unique source of public documentation. It started in 1873, documenting nearly all the major and minor policies being discussed and debated.
“ENDLESS FRONTIER ACT--Continued” mentioning Richard J. Durbin was published in the Senate section on pages S3492-S3496 on May 26.
Of the 100 senators in 117th Congress, 24 percent were women, and 76 percent were men, according to the Biographical Directory of the United States Congress.
Senators' salaries are historically higher than the median US income.
The publication is reproduced in full below:
ENDLESS FRONTIER ACT--Continued
Amendment No. 1588 to Amendment No. 1502
Mr. COONS. Mr. President, I rise to call up my amendment No. 1588, which is cosponsored by Senators Graham and Lujan, Barrasso, and Collins.
This amendment would establish a Foundation for Energy Security and Innovation, a nonprofit Foundation to support the Department of Energy's mission to help raise private capital to accelerate the commercialization of new and cutting-edge technologies.
As China has dramatically ramped up their R&D funding, our Federal funding has remained stagnant, threatening U.S. competitiveness and our potential to develop, bring to scale, and export clean energy technologies.
This amendment will take a model already proven by Foundations affiliated with the NIH, the CDC, the Department of Agriculture, and create a Foundation to channel private sector investments into our world-class scientific innovation institutions, our National Labs.
This new Foundation would support the great work already happening at the Department of Energy by leveraging public-private partnerships to address tech transfer barriers.
Working on this bill over the years, I have heard significant interest from the private sector and philanthropists looking for an entity to coordinate their investment.
This bipartisan and bicameral bill passed the House last year with the leadership of now Senator Lujan, and I urge my colleagues to support its passage.
I want to thank my partners, Senators Graham and Lujan, for their leadership and thank Senators Barrasso and Collins for cosponsoring, Senators Schumer and Manchin for their support, and Senators Wicker, Cantwell, and Young for their leadership on the Endless Frontier Act.
I yield the floor.
The PRESIDING OFFICER. The clerk will report the amendment by number.
The senior assistant legislative clerk read as follows:
The Senator from Delaware [Mr. Coons] proposes an amendment numbered 1588 to amendment No. 1502.
(The amendment is printed in the Record of May 19, 2021 under ``Text of Amendments.'')
Vote on Amendment No. 1588
The PRESIDING OFFICER. The question is on agreeing to the amendment.
Mr. COONS. Mr. President, I ask for the yeas and nays.
The PRESIDING OFFICER. Is there a sufficient second?
There appears to be a sufficient second.
The clerk will call the roll.
The legislative clerk called the roll.
Mr. DURBIN. I announce that the Senator from West Virginia (Mr. Manchin) is necessarily absent.
Mr. THUNE. The following Senators are necessarily absent: the Senator from Tennessee (Mrs. Blackburn) and the Senator from North Carolina
(Mr. Tillis).
The PRESIDING OFFICER (Ms. Baldwin). Are there any other Senators in the Chamber desiring to vote?
The result was announced--yeas 83, nays 14, as follows:
YEAS--83
BaldwinBarrassoBennetBlumenthalBluntBookerBoozmanBraunBrownBurrCantwellCapitoCardinCarperCaseyCassidyCollinsCoonsCornynCortez MastoCottonCramerDainesDuckworthDurbinErnstFeinsteinFischerGillibrandGrahamGrassleyHassanHeinrichHickenlooperHironoHoevenHyde-SmithInhofeKaineKellyKennedyKingKlobucharLankfordLeahyLujanMarkeyMcConnellMenendezMerkleyMoranMurkowskiMurphyMurrayOssoffPadillaPetersPortmanReedRomneyRosenRoundsRubioSandersSasseSchatzSchumerScott (SC)ShaheenSinemaSmithStabenowSullivanTesterThuneVan HollenWarnerWarnockWarrenWhitehouseWickerWydenYoung
NAYS--14
CrapoCruzHagertyHawleyJohnsonLeeLummisMarshallPaulRischScott (FL)ShelbyToomeyTuberville
NOT VOTING--3
BlackburnManchinTillis
The PRESIDING OFFICER. On this vote, the yeas are 83, the nays are 14.
Under the previous order requiring 60 votes for the adoption of this amendment, the amendment is agreed to.
The amendment (No. 1588) was agreed to.
Amendment No. 1929 to Amendment No. 1502
Mr. LEE. Madam President, I call up my amendment No. 1929 and ask that it be reported by number.
The PRESIDING OFFICER. The clerk will report the amendment by number.
The senior assistant legislative clerk read as follows:
The Senator from Utah [Mr. Lee] proposes an amendment numbered 1929 to amendment No. 1502.
(The amendment is printed in the Record of May 24, 2021, under ``Text of Amendments.'')
The PRESIDING OFFICER. There are now 2 minutes of debate, equally divided, on the amendment.
The Senator from Utah.
Mr. LEE. Madam President, the United States of America cannot meaningfully compete with Communist China. If our own government and if our own Federal regulatory system, one that 25 years ago was costing the American economy $300 billion a year and is now costing the American economy $2 trillion, if that regulatory system is hobbling us, we won't be able to compete.
That is why I introduced this amendment No. 1929, to bring the focus of the debate back to where it belongs--back to our regulatory challenges. It sets up a Regulatory Oversight and Review Task Force, composed of OMB, OIRA, and people in the private sector with expertise in this area.
The bipartisan task force would have, as its job, to conduct annually a review of all Federal regulations to figure out what is working, what is not working, what is harming American job growth, and what is helping.
Congress would then have the opportunity to review these recommendations and review recommendations in a way that would ultimately bring about regulatory reform helping us to compete with Communist China.
We can't beat China at its own game. We have to beat China by being our best selves. That is what amendment 1929 will do.
The PRESIDING OFFICER. The Senator from Michigan.
Mr. PETERS. Madam President, this measure undermines Federal Agencies' efforts to protect workers, consumers, our environment, and public health. When Federal Agencies create regulations, they must look at the full range of costs and benefits, including the impact on employers, workers, and vulnerable groups.
This measure shuts out most of these voices. It is designed to push Congress to repeal regulations without considering the concerns of workers who rely on Federal safety standards or communities whose water has been polluted by lead.
If Congress is concerned about a regulation, we already have tools to make the needed changes--either passing a law or using procedures like the Congressional Review Act. We need to move forward on bipartisan policies that will improve our Nation's competitiveness, not measures that will endanger our constituents and our communities. I urge my colleagues to vote no on amendment 1929.
Vote on Amendment No. 1929
Mr. LEE. I ask for the yeas and nays.
The PRESIDING OFFICER. The question is on agreeing to the amendment.
Is there a sufficient second?
Mr. DURBIN. Madam President.
The PRESIDING OFFICER. The Democratic whip.
Mr. DURBIN. Madam President, I ask unanimous consent the remaining votes tonight be 10-minute votes.
The PRESIDING OFFICER. Without objection, it is so ordered.
Is there a sufficient second?
There appears to be a sufficient second.
The clerk will call the roll.
The senior assistant legislative clerk called the roll.
Mr. DURBIN. I announce that the Senator from West Virginia (Mr. Manchin) is necessarily absent.
Mr. THUNE. The following Senators are necessarily absent: the Senator from Tennessee (Mrs. Blackburn) and the Senator from North Carolina
(Mr. Tillis).
The PRESIDING OFFICER. Are there any other Senators in the Chamber desiring to vote?
The result was announced--yeas 48, nays 49, as follows:
YEAS--48
BarrassoBluntBoozmanBraunBurrCapitoCassidyCollinsCornynCottonCramerCrapoCruzDainesErnstFischerGrahamGrassleyHagertyHawleyHoevenHyde-SmithInhofeJohnsonKennedyLankfordLeeLummisMarshallMcConnellMoranMurkowskiPaulPortmanRischRomneyRoundsRubioSasseScott (FL)Scott (SC)ShelbySullivanThuneToomeyTubervilleWickerYoung
NAYS--49
BaldwinBennetBlumenthalBookerBrownCantwellCardinCarperCasey CoonsCortez MastoDuckworthDurbinFeinsteinGillibrandHassanHeinrichHickenlooperHironoKaineKellyKingKlobucharLeahyLujanMarkeyMenendezMerkleyMurphyMurrayOssoffPadillaPetersReedRosenSandersSchatzSchumerShaheenSinemaSmithStabenowTesterVan HollenWarnerWarnockWarrenWhitehouseWyden
NOT VOTING--3
BlackburnManchinTillis
The PRESIDING OFFICER. On this vote, the yeas are 48, the nays are 49.
Under the previous order requiring 60 votes for adoption of this amendment, the amendment is not agreed to.
The amendment (No. 1929) was rejected.
The PRESIDING OFFICER. The Senator from Indiana.
Amendment No. 1771 to Amendment No. 1502
Mr. BRAUN. Madam President, I call up my amendment No. 1771 and ask that it be reported by number.
The PRESIDING OFFICER. The clerk will report.
The bill clerk read as follows:
The Senator from Indiana [Mr. Braun] proposes an amendment numbered 1771 to amendment No. 1502.
The amendment is as follows
(Purpose: To amend title 18, United States Code, to prohibit certain types of human-animal chimeras)
At the appropriate place, insert the following:
SEC. __. PROHIBITION ON CERTAIN HUMAN-ANIMAL CHIMERAS.
(a) In General.--Part I of title 18, United States Code, is amended by inserting after chapter 51 the following:
``CHAPTER 52--CERTAIN TYPES OF HUMAN-ANIMAL CHIMERAS PROHIBITED
``Sec.
``1131. Definitions.
``1132. Prohibition on human-animal chimeras.
``Sec. 1131. Definitions
``In this chapter:
``(1) Human embryo.--The term `human embryo' means an organism of the species Homo sapiens during the earliest stages of development, from 1 cell up to 8 weeks after conception.
``(2) Prohibited human-animal chimera.--The term
`prohibited human-animal chimera' means--
``(A) a human embryo into which a nonhuman cell or cells
(or the component parts thereof) have been introduced to render the embryo's membership in the species Homo sapiens uncertain;
``(B) a human-animal embryo produced by fertilizing a human egg with nonhuman sperm;
``(C) a human-animal embryo produced by fertilizing a nonhuman egg with human sperm;
``(D) an embryo produced by introducing a nonhuman nucleus into a human egg;
``(E) an embryo produced by introducing a human nucleus into a nonhuman egg;
``(F) an embryo containing at least haploid sets of chromosomes from both a human and a nonhuman life form;
``(G) a nonhuman life form engineered such that human gametes develop within the body of a nonhuman life form;
``(H) a nonhuman life form engineered such that it contains a human brain or a brain derived wholly or predominantly from human neural tissues;
``(I) nonhuman life form engineered such that it exhibits human facial features or other bodily morphologies to resemble human features; or
``(J) an embryo produced by mixing human and nonhuman cells, such that--
``(i) human gametes develop within the body of the resultant organism;
``(ii) it contains a human brain or a brain derived wholly or predominantly from human neural tissues; or
``(iii) it exhibits human facial features or other bodily morphologies to resemble human features.
``Sec. 1132. Prohibition on certain human-animal chimeras
``(a) In General.--It shall be unlawful for any person to knowingly, in or otherwise affecting interstate commerce--
``(1) create or attempt to create a prohibited human-animal chimera;
``(2) transfer or attempt to transfer a human embryo into a nonhuman womb;
``(3) transfer or attempt to transfer a nonhuman embryo into a human womb; or
``(4) transport or receive for any purpose a prohibited human-animal chimera.
``(b) Penalties.--
``(1) In general.--Whoever violates subsection (a) shall be fined under this title, imprisoned not more than 10 years, or both.
``(2) Civil penalty.--Whoever violates subsection (a) shall be subject to a civil fine of the greater of--
``(A) $1,000,000; or
``(B) the amount equal to twice the amount of the gross pecuniary gain, if any.
``(c) Rule of Construction.--This section does not prohibit research involving the use of transgenic animal models containing human genes or transplantation of human organs, tissues, or cells into recipient animals, if such activities are not prohibited under subsection (a).''.
(b) Technical Amendment.--The table of chapters for part I of title 18, United States Code, is amended by inserting after the item relating to chapter 51 the following:
``52. Certain types of human-animal chimeras prohibited1131.''.........
Mr. BRAUN. Madam President, in recent years, research involving human-animal hybrids has become much more prevalent. For example, in April, researchers in China created a monkey-human hybrid embryo that they allowed to grow and studied for weeks.
I have serious ethical concerns with this type of human chimera research. My amendment would ban the practice by applying the NIH's current anti-chimera policy universally.
Due to the dangerous and offensive nature of this research, my amendment imposes penalties on those who participate in this unethical research.
We must act now. Just this morning, the International Society for Stem Cell Research, an international standards-setting body, issued guidance that permits the creation of human-animal hybrids. I ask that my Senate colleagues reject this foreign position and maintain our own NIH's ethical standards.
All life is sacred. It is Congress's responsibility to enact commonsense bioethics.
The PRESIDING OFFICER. The Senator's time has expired.
Mr. BRAUN. Please support this amendment.
The PRESIDING OFFICER. The senior Senator from Washington.
Mrs. MURRAY. Madam President, I was just here yesterday reminding my colleagues that this is a bipartisan bill to help families across our country by boosting American's competitiveness. I have said it already. I will say it again. That means we have to ensure that American research is guided by science, not ideology.
This amendment does the exact opposite and undermines scientifically significant research that could actually help develop new treatments and ultimately lead to lifesaving organ transplants.
If we are serious about bipartisan commitment to American innovation, we have to stop these ideological attacks on medical research and focus on the science and ultimately the health of our patients.
I urge a ``no'' vote. Thank you.
Vote on Amendment No. 1771
The PRESIDING OFFICER. The question is on agreeing to the amendment.
Mr. BRAUN. I ask for the yeas and nays.
The PRESIDING OFFICER. Is there a sufficient second?
There appears to be a sufficient second.
The clerk will call the roll.
The bill clerk called the roll.
Mr. DURBIN. I announce that the Senator from West Virginia (Mr. Manchin) is necessarily absent.
Mr. THUNE. The following Senators are necessarily absent: the Senator from Tennessee (Mrs. Blackburn) and the Senator from North Carolina
(Mr. Tillis).
The PRESIDING OFFICER. Are there any other Senators in the Chamber desiring to vote or change their vote?
The result was announced--yeas 48, nays 49, as follows:
YEAS--48
BarrassoBluntBoozmanBraunBurrCapitoCassidyCollinsCornynCottonCramerCrapoCruzDainesErnstFischerGrahamGrassleyHagertyHawleyHoevenHyde-SmithInhofeJohnsonKennedyLankfordLeeLummisMarshallMcConnellMoranMurkowskiPaulPortmanRischRomneyRoundsRubioSasseScott (FL)Scott (SC)ShelbySullivanThuneToomeyTubervilleWickerYoung
NAYS--49
BaldwinBennetBlumenthalBookerBrownCantwellCardinCarperCaseyCoonsCortez MastoDuckworthDurbinFeinsteinGillibrandHassanHeinrichHickenlooperHironoKaineKellyKingKlobucharLeahyLujanMarkeyMenendezMerkleyMurphyMurrayOssoffPadillaPetersReedRosenSandersSchatzSchumerShaheenSinemaSmithStabenowTester Van HollenWarnerWarnockWarrenWhitehouseWyden
NOT VOTING--3
BlackburnManchinTillis
The PRESIDING OFFICER. On this vote, the yeas are 48, the nays are 49.
Under the previous order requiring 60 votes for the adoption of this amendment, the amendment is rejected.
The amendment (No. 1771) was rejected.
The junior Senator from Kansas.
Amendment No. 1973, as Modified, to Amendment No. 1502
Mr. MARSHALL. Madam President, I call up my amendment No. 1973, as modified, with the changes at the desk and ask that it be reported by number.
The PRESIDING OFFICER. The clerk will report the amendment.
The senior assistant legislative clerk read as follows:
The Senator from Kansas [Mr. Marshall] proposes an amendment numbered 1973, as modified, to amendment No. 1502.
The amendment, as modified, is as follows
(Purpose: To express the sense of the Senate regarding the need to conduct a comprehensive investigation to determine the origins of
COVID-19, and for other purposes)
At the appropriate place, insert the following:
SEC. ____. FINDINGS AND SENSE OF THE SENATE REGARDING AN
INVESTIGATION TO DETERMINE THE ORIGINS OF
COVID-19.
(a) Findings.--Congress finds the following:
(1) COVID-19 has taken the lives of nearly 3,500,000 individuals around the world.
(2) Understanding the origins of the COVID-19 pandemic is essential to addressing our vulnerabilities and preventing future crises.
(3) In May 2020, the World Health Assembly did not authorize a comprehensive investigation into the origins of COVID-19, and instead passed a significantly limited compromise resolution, with Chinese government support, which did not explicitly include in its scope the possibility of a research-related accident.
(4) The 2020 World Health Assembly resolution and its terms of reference, which were negotiated privately between the World Health Organization (in this section referred to as
``WHO'') and Chinese authorities, handed the Chinese government control over the joint-study process by giving the Chinese government veto power over which international experts were allowed to participate in the joint study and by agreeing that most primary research would be carried out by Chinese teams without ensuring broad access to primary data by international experts.
(5) As a result of these terms, the significant structural, procedural, and analytical shortcomings of the joint study, and the severe restrictions imposed by Chinese authorities, the WHO-convened joint study into the origins of COVID-19 was prevented from providing a balanced consideration of the multiple theories of the origin of COVID-19.
(6) Only 4 of the 313 pages of the joint-study team report and its annexes addressed the possibility of a laboratory accident, and no thorough examination of the lab incident hypothesis was carried out by the joint-study team.
(7) Some of the international experts on the joint-study team stated that they lacked the means and resources to properly investigate the research-related accident hypothesis, and they were neither able nor meant to do such a full investigation but instead were acting as a ``study review group''.
(8) WHO Director-General Dr. Tedros Adhanom Ghebreyesus commented on March 30, 2021, the day the joint-study report was released, ``I do not believe that [the joint-study team's] assessment [of a possible lab incident] was extensive enough. Further data and studies will be needed to reach more robust conclusions . . . potentially with additional missions involving specialist experts, which I am ready to deploy.''.
(9) The WHO Director-General further commented, ``As far as WHO is concerned all hypotheses remain on the table . . . We have not yet found the source of the virus, and we must continue to follow the science and leave no stone unturned as we do . . . It is clear that we need more research across a range of areas, which will entail further field visits.''.
(10) The March 30, 2021 Joint Statement on the WHO-convened COVID-19 Origins Study by the United States and 13 other countries recognized the severe shortcomings of the joint-study process and called for ``a transparent and independent analysis and evaluation, free from interference and undue influence.''.
(11) In spite of the devastation the COVID-19 pandemic has caused in the United States and around the world, no process currently exists to ensure a comprehensive investigation into the source of COVID-19.
(12) Such an investigation is essential for ensuring this type of crisis never happens again for the benefit of all people, all nations, and future generations.
(b) Sense of the Senate.--It is the sense of the Senate that--
(1) a comprehensive investigation to determine the origins of COVID-19 must be conducted by WHO immediately, with access to all relevant records, samples, and personnel in China, and that such investigation must fully explore all possible sources of the COVID-19 pandemic, including exclusively
``natural'' zoonosis in the wild, human contamination in an animal farm, and a research-related accident;
(2) the United States delegation to the World Health Assembly should, in concert with allies and partners around the world, work to ensure that an international scientific investigation into the origins of COVID-19, with full access to all relevant records, samples, and personnel in China, will be authorized by the World Health Assembly and implemented with extreme urgency; and
(3) should such a full investigation not be authorized by the 2021 World Health Assembly, then the United States Government should immediately begin planning a comprehensive and data-driven investigation into the COVID-19 pandemic origins, in concert with willing partner governments and experts around the world.
The PRESIDING OFFICER. There are now 2 minutes of debate, equally divided, on the amendment.
Mr. MARSHALL. Madam President, over the past year, COVID-19 has spread to all corners of the world, killing more than 3 million people in its path, including more than 550,000 Americans. We were originally told this virus initiated in a wet market or that it may have come from a bat that directly infected a human. However, the preponderance of evidence now suggests this virus may have leaked from a lab in Wuhan.
With the World Health Assembly meeting this week, I ask this body to fully express support for a complete investigation into this outbreak. It is outrageous and inconceivable that a comprehensive investigation has still not occurred.
If China continues on its path of coverup, we must begin planning a full investigation, including with partners around the world. It would be utterly irresponsible to suffer through the worst pandemic in a century and not have the origins fully investigated.
Our bipartisan amendment will deliver the message that the Chinese must show us the data and be transparent with the world, and if they don't, we will fight to get to the bottom of this pandemic.
I thank Senator Gillibrand for introducing this amendment with me and ask that all Senators join us in approving it, and we hope, we believe, that this can pass with a voice vote.
Thank you. And I yield.
Mrs. GILLIBRAND. Mr. President, I yield back all time, and I support this amendment.
The PRESIDING OFFICER. Without objection, all time is yielded back.
Vote on Amendment No. 1973
Ms. CANTWELL. Madam President, I ask unanimous consent to vitiate the 60-vote threshold for this amendment.
The PRESIDING OFFICER. Is there objection?
Without objection, it is so ordered.
The question is on agreeing to the amendment.
The amendment (No. 1973), as modified, was agreed to.
The PRESIDING OFFICER. The Senator from Nebraska.
Amendment No. 2023 to Amendment No. 1502
Mr. SASSE. Madam President, I would like to call up my amendment No. 2023 and ask that it be reported by number.
The PRESIDING OFFICER. The clerk will report the amendment by number.
The bill clerk read as follows:
The Senator from Nebraska [Mr. Sasse] proposes amendment numbered 2023 to amendment No. 1502.
The amendment is as follows
(Purpose: To authorize appropriations for the Defense Advanced Research
Projects Agency to conduct research and development in key technology focus areas)
At the appropriate place in division B, insert the following:
SEC. ___. AUTHORIZATION OF APPROPRIATIONS FOR THE DEFENSE
ADVANCED RESEARCH PROJECTS AGENCY.
(a) In General.--Notwithstanding any other provision of law, there is authorized to be appropriated for the Defense Advanced Research Projects Agency to conduct research and development in key technology focus areas $3,500,000,000 for each of fiscal years 2022 through 2026.
(b) Supplement, Not Supplant.--Any amount appropriated pursuant to the authorization in subsection (a) shall supplement and not supplant any amounts already appropriated for the Defense Advanced Research Projects Agency.
The PRESIDING OFFICER. The Senator from Nebraska.
Mr. SASSE. Madam President, my amendment about doubling DARPA funding is really simple: It doubles DARPA funding. This amendment would provide an additional $3.5 billion a year to the base, $3.5 billion that DARPA currently receives over the next 5 years.
To members of the Armed Services Committee, I would tell you, this amendment doesn't do anything to mess with your base authorization. Your work is not displaced. This is simply additive. Modern war isn't just about enemy landings; it is also about enemy hackings. And the Chinese Communist Party is currently pouring money into machine learning, AI, and quantum because they think if they achieve first-
mover advantage in cyber, they will ultimately become the world's preeminent superpower. DARPA's job is to make sure that doesn't happen.
We to need to make sure that Chairman Xi lies awake at night worrying about his critical infrastructure, his networks, and his vulnerabilities. And DARPA is currently doing that work, but DARPA is not funded for us to win the technology race.
Money that goes to NSF, which is the core of the bill that is before us----
The PRESIDING OFFICER. The Senator's time has expired.
Mr. SASSE (continuing). Is important, but DARPA is different. DARPA is the one that leads Chairman Xi to be worried at night.
I request a ``yes'' vote.
The PRESIDING OFFICER. Who yields time?
Mr. SASSE. I ask for a recorded vote, and I ask for the yeas and nays.
Vote on Amendment No. 2023
The PRESIDING OFFICER. The question is on agreeing to the amendment.
Is there a sufficient second?
There is a sufficient second.
The clerk will call the roll.
The senior assistant legislative clerk called the roll.
Mr. DURBIN. I announce that the Senator from West Virginia (Mr. Manchin) is necessarily absent.
Mr. THUNE. The following Senators are necessarily absent: the Senator from Tennessee (Mrs. Blackburn) and the Senator from North Carolina
(Mr. Tillis).
The PRESIDING OFFICER. Are there any other Senators in the Chamber desiring to vote?
The result was announced--yeas 67, nays 30, as follows:
YEAS--67
BarrassoBennetBlumenthalBluntBoozmanBurrCantwellCapitoCaseyCollinsCoonsCornynCortez MastoCottonCramerCruzDainesDurbinErnstFischerGillibrandGrahamHagertyHassanHeinrichHickenlooperHoevenHyde-SmithInhofeKaineKellyKennedyKingLujanMarshallMcConnellMoranMurkowskiMurphyMurrayOssoffPadillaPetersPortmanRomneyRosenRoundsRubioSasseSchatzSchumerScott (FL)Scott (SC)ShaheenShelbySinemaStabenowSullivanTesterThuneVan HollenWarnerWarnockWarrenWhitehouseWickerYoung
NAYS--30
BaldwinBookerBraunBrownCardinCarperCassidyCrapoDuckworthFeinsteinGrassleyHawleyHironoJohnsonKlobucharLankfordLeahyLeeLummisMarkeyMenendezMerkleyPaulReedRischSandersSmithToomeyTubervilleWyden
NOT VOTING--3
BlackburnManchinTilli
The PRESIDING OFFICER. On this vote, the yeas are 67, the nays are 30.
Under the previous order requiring 60 votes for the adoption of this amendment, the amendment is agreed to.
The amendment (No. 2023) was agreed to.
The PRESIDING OFFICER. The majority leader.
____________________
Alerts Sign-up